🚀 VC round data is live in beta, check it out!
Stevanato Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Stevanato Group and similar public comparables like Sotera Health, Ansell, Haemonetics, Dentsply Sirona and more.
Stevanato Group Overview
About Stevanato Group
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
Founded
1980
HQ
Employees
5.5K
Website
Financials (LTM)
EV
$5B
Stevanato Group Financials
Stevanato Group reported last 12-month revenue of $1B and EBITDA of $357M.
In the same LTM period, Stevanato Group generated $410M in gross profit, $357M in EBITDA, and $169M in net income.
Revenue (LTM)
Stevanato Group P&L
In the most recent fiscal year, Stevanato Group reported revenue of $1B and EBITDA of $347M.
Stevanato Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $410M | XXX | $398M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBITDA | $357M | XXX | $347M | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 25% | XXX | XXX | XXX |
| EBIT Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| Net Profit | $169M | XXX | $163M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| Net Debt | — | — | $375M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Stevanato Group Stock Performance
Stevanato Group has current market cap of $4B, and enterprise value of $5B.
Market Cap Evolution
Stevanato Group's stock price is $15.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $4B | 0.0% | XXX | XXX | XXX | $0.60 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialStevanato Group Valuation Multiples
Stevanato Group trades at 3.2x EV/Revenue multiple, and 12.6x EV/EBITDA.
EV / Revenue (LTM)
Stevanato Group Financial Valuation Multiples
As of March 28, 2026, Stevanato Group has market cap of $4B and EV of $5B.
Equity research analysts estimate Stevanato Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Stevanato Group has a P/E ratio of 24.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 3.2x | XXX | 3.3x | XXX | XXX | XXX |
| EV/EBITDA | 12.6x | XXX | 13.0x | XXX | XXX | XXX |
| EV/EBIT | 18.1x | XXX | 18.5x | XXX | XXX | XXX |
| EV/Gross Profit | 11.0x | XXX | 11.4x | XXX | XXX | XXX |
| P/E | 24.4x | XXX | 25.3x | XXX | XXX | XXX |
| EV/FCF | 276.5x | XXX | 210.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Stevanato Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Stevanato Group Margins & Growth Rates
Stevanato Group's revenue in the last 12 month grew by 7%.
Stevanato Group's revenue per employee in the last FY averaged $0.3M.
Stevanato Group's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Stevanato Group's rule of X is 44% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Stevanato Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 33% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 8% | XXX | 8% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Stevanato Group Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sotera Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Haemonetics | XXX | XXX | XXX | XXX | XXX | XXX |
| Dentsply Sirona | XXX | XXX | XXX | XXX | XXX | XXX |
| Inner Mongolia Furui Medical Science | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Stevanato Group M&A Activity
Stevanato Group acquired XXX companies to date.
Last acquisition by Stevanato Group was on XXXXXXXX, XXXXX. Stevanato Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Stevanato Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialStevanato Group Investment Activity
Stevanato Group invested in XXX companies to date.
Stevanato Group made its latest investment on XXXXXXXX, XXXXX. Stevanato Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Stevanato Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Stevanato Group
| When was Stevanato Group founded? | Stevanato Group was founded in 1980. |
| Where is Stevanato Group headquartered? | Stevanato Group is headquartered in Italy. |
| How many employees does Stevanato Group have? | As of today, Stevanato Group has over 5K employees. |
| Who is the CEO of Stevanato Group? | Stevanato Group's CEO is Franco Stevanato. |
| Is Stevanato Group publicly listed? | Yes, Stevanato Group is a public company listed on NYSE. |
| What is the stock symbol of Stevanato Group? | Stevanato Group trades under STVN ticker. |
| When did Stevanato Group go public? | Stevanato Group went public in 2021. |
| Who are competitors of Stevanato Group? | Stevanato Group main competitors are Sotera Health, Ansell, Haemonetics, Dentsply Sirona. |
| What is the current market cap of Stevanato Group? | Stevanato Group's current market cap is $4B. |
| What is the current revenue of Stevanato Group? | Stevanato Group's last 12 months revenue is $1B. |
| What is the current revenue growth of Stevanato Group? | Stevanato Group revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Stevanato Group? | Current revenue multiple of Stevanato Group is 3.2x. |
| Is Stevanato Group profitable? | Yes, Stevanato Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Stevanato Group? | Stevanato Group's last 12 months EBITDA is $357M. |
| What is Stevanato Group's EBITDA margin? | Stevanato Group's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Stevanato Group? | Current EBITDA multiple of Stevanato Group is 12.6x. |
| What is the current FCF of Stevanato Group? | Stevanato Group's last 12 months FCF is $16M. |
| What is Stevanato Group's FCF margin? | Stevanato Group's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Stevanato Group? | Current FCF multiple of Stevanato Group is 276.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.